Discontinuation report NIASTASE RT
| Report ID | 27590 |
| Drug Identification Number | 02347121 |
| Brand name | NIASTASE RT |
| Common or Proper name | Eptacog Alfa (activated) |
| Company Name | NOVO NORDISK CANADA INC |
| Market Status | APPROVED |
| Active Ingredient(s) | EPTACOG ALFA |
| Strength(s) | 2MG |
| Dosage form(s) | KIT POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | One vial of 2mg (100 KIU) per carton |
| ATC code | B02BD |
| ATC description | VITAMIN K AND OTHER HEMOSTATICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2017-10-27 |
| Actual discontinuation date | 2017-10-27 |
| Remaining supply date | 2017-10-27 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | no supply remaining |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 101-2476 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 6M1 |
| Company contact information | 1 800 465 4334 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2017-10-31 | French | Compare |
| v1 | 2017-10-31 | English | Compare |
Showing 1 to 2 of 2